Does EVEROLIMUS Cause Thrombotic microangiopathy? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Thrombotic microangiopathy have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.5% of all adverse event reports for EVEROLIMUS.
192
Reports of Thrombotic microangiopathy with EVEROLIMUS
0.5%
of all EVEROLIMUS reports
20
Deaths
101
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From EVEROLIMUS?
Of the 192 reports, 20 (10.4%) resulted in death, 101 (52.6%) required hospitalization, and 13 (6.8%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which EVEROLIMUS Alternatives Have Lower Thrombotic microangiopathy Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE